ACADIAN ASSET MANAGEMENT LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 916542 Boston, MA

Position in CRBP

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,021,556

+$531,618 QoQ

Shares Held

108,792

+80.8% QoQ

Ownership

0.587%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. CRBP ranks #63 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,021,556	108,792	+80.8%	Shares	Defined	2026-05-13
2025-12-31	$489,938	60,189	-28.2%	Shares	Defined	2026-02-10
2025-09-30	$1,060,310	83,819	-45.0%	Shares	Defined	2025-11-13
2025-06-30	$1,050,669	152,271	-19.9%	Shares	Defined	2025-08-07
2025-03-31	$1,009,393	190,093	+4338.3%	Shares	Defined	2025-05-21
2024-09-30	$88,358	4,283	-73.0%	Shares	Defined	2024-11-12
2024-06-30	$717,393	15,854	—	Shares	Defined	2024-08-06
No filing history on record for this holder in this stock.